SOTIO Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 201
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1
  • Investments
  • 6

SOTIO General Information

Description

Developer of Active Cellular Immunotherapy (ACI) based on activated dendritic cells for the treatment of cancer and autoimmune diseases. The company operates as a biotechnology firm which develops new therapies to address unmet medical needs using its immunotherapy platform and proprietary cell-based technologies, enabling state-of-the-art immunotherapy treatment for its patients in Prague, Czech Republic.

Contact Information

Website
www.sotio.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Drug Discovery
Primary Office
  • Jankovcova 1518/2
  • Prague, 170 00
  • Czech Republic
+420 224 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SOTIO Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SOTIO‘s full profile, request access.

Request a free trial

SOTIO Executive Team (13)

Name Title Board Seat Contact Info
Radek Špíšek Ph.D Global Chief Executive Officer
Pavel Solský Chief Financial & Commercial Officer
Jiří Lísal Chief Operating Officer
Luděk Sojka Ph.D Chief Technology Officer
Jens Hennecke Ph.D Chief Business Officer
You’re viewing 5 of 13 executive team members. Get the full list »

SOTIO Board Members (5)

Name Representing Role Since
000 00000000 000000 PPF Group Board Member 000 0000
00ř000 0000ůň000á Self Chairman of the Supervisory Board 000 0000
000000 000 000000 Self Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

SOTIO Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SOTIO Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SOTIO‘s full profile, request access.

Request a free trial

SOTIO Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000000 28-Aug-2020 0000000000 00.00 Drug Discovery
000000000 0000000 17-Dec-2019 00000 00000 00 0000 Drug Discovery 00000 Š0íš00 00.0
0000000 00000000 14-Oct-2019 00000 00000 00 00.00 Drug Discovery 00000 Š0íš00 00.0
000000 000000 30-Aug-2018 0000000000 Biotechnology 00000 Š0íš00 00.0
Accord Research 31-Dec-2014 Buyout/LBO Other Commercial Services
You’re viewing 5 of 6 investments. Get the full list »

SOTIO Subsidiaries (1)

Company Name Industry Location Founded
000000 00000000 Other Commercial Services Prague, Czech Republic 0000
To view SOTIO’s complete subsidiaries history, request access »